Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tom Missotten

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Journal of Cataract and Refractive Surgery|October 12, 2004
Optical formula to predict outcomes after implantation of accommodating intraocular lensesTom Missotten, Thibault Verhamme, Johan Blanckaert, et al.
Acta Ophthalmologica|August 28, 2015
Updated cannulation technique for tissue plasminogen activator injection into peripapillary retinal vein for central retinal vein occlusionKoen A van Overdam, Tom Missotten, Leigh H Spielberg
Investigative Ophthalmology & Visual Science|February 1, 2008
Influence of intraoperative course on visual outcome after an RPE-choroid translocationKristel Maaijwee, Tom Missotten, Paul Mulder, et al.
Statistics in Medicine|December 21, 2018
A joint model for dynamic prediction in uveitisMia Klinten Grand, Koenraad Arndt Vermeer, Tom Missotten, et al.
Ophthalmology|December 23, 2006
Acute retinal necrosis features, management, and outcomesChun H Lau, Tom Missotten, Joel Salzmann, et al.
Acta Ophthalmologica|January 8, 2013
Vision-related quality of life in patients with birdshot chorioretinopathyJonas J W Kuiper, Tom Missotten, Seerp G Baarsma, et al.
Acta Ophthalmologica|September 30, 2016
Early surgical treatment of retinal hemangioblastomasKoen A van Overdam, Tom Missotten, Emine Kilic, et al.
Plos One|February 23, 2017
SF-6D utility values for the better- and worse-seeing eye for health states based on the Snellen equivalent in patients with age-related macular degenerationMartijn S Visser, Sankha Amarakoon, Tom Missotten, et al.
Molecular Vision|April 10, 2007
Polymorphisms of chemokine and chemokine receptor genes in idiopathic immune-mediated posterior segment uveitisMuhammad A Ahad, Tom Missotten, Atiyeh Abdallah, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|July 16, 2020
Six and eight weeks injection frequencies of bevacizumab are non-inferior to the current four weeks injection frequency for quality of life in neovascular age-related macular degeneration: a randomized controlled trialMartijn S Visser, Sankha Amarakoon, Tom Missotten, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Journal of Cataract and Refractive Surgery|October 12, 2004
Optical formula to predict outcomes after implantation of accommodating intraocular lensesTom Missotten, Thibault Verhamme, Johan Blanckaert, et al.
Acta Ophthalmologica|August 28, 2015
Updated cannulation technique for tissue plasminogen activator injection into peripapillary retinal vein for central retinal vein occlusionKoen A van Overdam, Tom Missotten, Leigh H Spielberg
Investigative Ophthalmology & Visual Science|February 1, 2008
Influence of intraoperative course on visual outcome after an RPE-choroid translocationKristel Maaijwee, Tom Missotten, Paul Mulder, et al.
Statistics in Medicine|December 21, 2018
A joint model for dynamic prediction in uveitisMia Klinten Grand, Koenraad Arndt Vermeer, Tom Missotten, et al.
Ophthalmology|December 23, 2006
Acute retinal necrosis features, management, and outcomesChun H Lau, Tom Missotten, Joel Salzmann, et al.
Acta Ophthalmologica|January 8, 2013
Vision-related quality of life in patients with birdshot chorioretinopathyJonas J W Kuiper, Tom Missotten, Seerp G Baarsma, et al.
Acta Ophthalmologica|September 30, 2016
Early surgical treatment of retinal hemangioblastomasKoen A van Overdam, Tom Missotten, Emine Kilic, et al.
Plos One|February 23, 2017
SF-6D utility values for the better- and worse-seeing eye for health states based on the Snellen equivalent in patients with age-related macular degenerationMartijn S Visser, Sankha Amarakoon, Tom Missotten, et al.
Molecular Vision|April 10, 2007
Polymorphisms of chemokine and chemokine receptor genes in idiopathic immune-mediated posterior segment uveitisMuhammad A Ahad, Tom Missotten, Atiyeh Abdallah, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|July 16, 2020
Six and eight weeks injection frequencies of bevacizumab are non-inferior to the current four weeks injection frequency for quality of life in neovascular age-related macular degeneration: a randomized controlled trialMartijn S Visser, Sankha Amarakoon, Tom Missotten, et al.
Pageof 4